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Abstract
Background: Studies of gene expression in experimental cerebral ischaemia models can contribute to
understanding the pathophysiology of brain ischaemia and to identifying prognostic markers and potential
therapeutic targets. The normalization of relative qRT-PCR data using a suitable reference gene is a crucial
prerequisite for obtaining reliable conclusions. No validated housekeeping genes have been reported for
the relative quantification of the mRNA expression profile activated in in-vitro ischaemic conditions,
whereas for the in-vivo model different reference genes have been used.
The present study aims to determine the expression stability of ten housekeeping genes (Gapdh, β2m,
Hprt, Ppia, Rpl13a, Oaz1, 18S rRNA, Gusb, Ywhaz and Sdha) to establish their suitability as control genes
for in-vitro and in-vivo cerebral ischaemia models.
Results: The expression stability of the candidate reference genes was evaluated using the 2-ΔC'T method
and ANOVA followed by Dunnett's test. For the in-vitro model using primary cultures of rat astrocytes,
all genes analysed except for Rpl13a and Sdha were found to have significantly different levels of mRNA
expression. These different levels were also found in the case of the in-vivo model of pMCAO in rats
except for Hprt, Sdha and Ywhaz mRNA, where the expression did not vary. Sdha and Ywhaz were
identified by geNorm and NormFinder as the two most stable genes.
Conclusion: We have validated endogenous control genes for qRT-PCR analysis of gene expression in
in-vitro and in-vivo cerebral ischaemia models. For normalization purposes, Rpl13a and Sdha are found to
be the most suitable genes for the in-vitro model and Sdha and Ywhaz for the in-vivo model. Genes
previously used as housekeeping genes for the in-vivo model in the literature were not validated as good
control genes in the present study, showing the need for careful evaluation for each new experimental
setup.
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Background
Oxygen-glucose deprivation (OGD) and middle cerebral
artery occlusion (MCAO) are accepted as in-vitro and in-
vivo cerebral ischaemia models [1-4]. The permanent
MCAO (pMCAO) focal ischaemia model is widely used in
stroke research and is helpful in elucidating physiopatho-
logical causes and identifying prognostic markers and
potential therapeutic targets [5-9].
Real-time polymerase chain reaction (RT-PCR) is a power-
ful technique for gene expression studies due to its high
sensitivity, specificity and broad quantification range for
high throughput and accurate expression profiling of
selected genes [10]. The data obtained by quantitative RT-
PCR (qRT-PCR) is typically normalised with an internal
control, often referred to as a housekeeping gene. Up to
now, several mathematical methods, such as NormFinder
[11], geNorm [12] and 2-ΔC'T method [13], have been devel-
oped to analyse the variability of the expression of candi-
date housekeeping genes. The ideal housekeeping gene for
qRT-PCR would be one whose mRNA is consistently
expressed at the same level in all samples under investiga-
tion, regardless of tissue type, disease state, medication or
experimental conditions, and would have expression levels
comparable to that of the target [14,15]. However, no ideal
reference gene has yet been discovered and it is reasonable
to suppose that such a gene may not exist. Although differ-
ent genes have been used, several previous studies have
shown that the suitability of a particular reference gene
depends on the insult, lesion and experimental conditions
applied to the cell culture or experimental animal [16,17].
Therefore, careful evaluation and validation of control
genes is required prior to using them in each individual
case to avoid possible inaccuracies stemming from the use
of an unsuitable reference gene [14,16,18-20].
In addition, no validated housekeeping genes have been
reported for the relative quantification of the mRNA
expression profile activated in in-vitro ischaemic condi-
tions. With regards to the in-vivo model (pMCAO), Glyc-
eraldehyde-3-phosphate dehydrogenase (Gapdh) [16,21,22],
Peptidyl-prolyl cis-trans isomerasa (Ppia) [21-23], Ribosomal
Protein L13A (Rpl13a)[23] and Hypoxanthine phosphoribo-
syltransferase (Hprt) [16] have previously been accepted as
control genes. The aim of this study was to confirm the
validity of these reference genes in our pMCAO samples
and to test their usefulness as endogenous controls in the
in-vitro model using primary cultures of rat astrocytes.
Furthermore, we aimed to analyse the expression stability
of other reference genes that have been used, Beta-2
microglobulin (β2m) and 18S rRNA [24], Glucoronidase B
(Gusb) [25], Succinate dehydrogenase complex, subunit A
(Sdha) [14,25,26], Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide (Ywhaz)
[14,26] and a new candidate gene for the in-vivo model,
Ornithine decarboxylase antizyme 1 (Oaz1), which has been
hypothesised as being suitable in experimental conditions
involving high protein turn-over [10].
Results
Evaluation and validation of selected candidate 
housekeeping genes in an in-vitro ischaemia model
The results of gene expression of Gapdh, Hprt, Ppia, 18S
rRNA, β2m, Oaz1, Gusb, Ywhaz, Sdha and Rpl13a from
astrocytes exposed to OGD during 3 hours and collected
at 0 minutes, 30 minutes, 2, 6, 24 and 48 hours after
reperfusion are shown in Figure 1.
The expression of Gapdh was found to have significant
fluctuations in the levels of mRNA (p < 0.0001) increasing
significantly at 0 h after reperfusion (p < 0.05) whereas no
significant differences were observed at other points (Fig-
ure 1A). The expression of Hprt, in comparison to the con-
trol group, was found to fluctuate significantly in all the
groups as a whole (p < 0.0001). This fluctuation was a sig-
nificant increase at 0 min (p < 0.0001), 30 min (p < 0.01)
and 6 h after reperfusion (p < 0.0001) (Figure 1B). Signif-
icant differences in the expression of Ppia were found
between time groups (p < 0.0001). Levels increased at 0
and 30 min (p < 0.0001 in both cases) and at 2 h and 6 h
(p < 0.05 in both cases) after reperfusion in comparison
with the control group (Figure 1C). The 18S rRNA mRNA
showed significant level fluctuations (p < 0.0001). Levels
decreased at 24 h (p < 0.01) and 48 h (p < 0.0001) after
reperfusion (Figure 1D). Changes in β2m mRNA levels
were found to be significant between time groups (p <
0.0001). β2m expression decreased at 0 min (p < 0.01),
30 min and 6 h (p < 0.0001 in both cases) and 48 h (p <
0.05) in comparison with the control group (Figure 1E).
Oaz1 also showed significant differences in expression
between groups (p < 0.0001). The expression was stable at
the first four analysis times but decreased significantly at
24 h (p < 0.01) and 48 h (p < 0.05) (Figure 1F). Significant
fluctuations in the mRNA expression of Gusb were found
(p < 0.0001) decreasing at 2 h after reperfusion (p <
0.0001) (Figure 1G). The expression of Ywhaz was found
to have significant fluctuations in mRNA levels (p <
0.0001) (Figure 1H). Analysis of the same samples with a
specific gene expression assay for Sdha and Rpl13a did not
reveal any significant differences in expressions at the dif-
ferent time points when analysis was made (p = 0.065 and
p = 0.244, respectively) (Figure 1I and 1J).
Evaluation and validation of selected candidate 
housekeeping genes in an in-vivo cerebral ischaemia model
The gene expression of candidate housekeeping genes,
β2m, Rpl13a, Oaz1, Gapdh, Ppia, Gusb, 18SrRNA, Sdha,
Ywhaz and Hprt, in cerebral cortex samples collected at 30
minutes and 2, 6, 24, 48 and 72 hours after pMCAO is
shown in Figure 2.BMC Molecular Biology 2009, 10:57 http://www.biomedcentral.com/1471-2199/10/57
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β2m expression presented a significant increase at 48 and
72 h (p < 0.0001 in both cases) and was significantly dif-
ferent between groups (p < 0.0001) (Figure 2A). The
expression of Rpl13a increased 72 h after pMCAO (p <
0.05) with a significant fluctuation between groups (p <
0.01) (Figure 2B). The level of mRNA variation of Oaz1
was found to be significant for all the time groups taken
as a whole (p < 0.01) (Figure 2C). Significant differences
were found between groups for the expression of Ppia (p
< 0.0001) with mRNA decreasing significantly at 2 and 6
h (p < 0.01 in both cases) after pMCAO (Figure 2D). The
expression of Gusb was found to fluctuate significantly
between the different test points (p < 0.0001). At 48 h and
72 h, levels of Gusb mRNA had increased (p < 0.01 and p
< 0.0001 respectively) (Figure 2E). The level of the mRNA
of 18S rRNA showed significant fluctuation (p < 0.05)
Effects of OGD in astrocyte expression of housekeeping genes: (A) Gapdh, (B) Hprt, (C) Ppia, (D) 18S rRNA, (E) β2m, (F)  Oaz1, (G) Gusb, (H) Ywhaz, (I) Sdha and (J) Rpl13a Figure 1
Effects of OGD in astrocyte expression of housekeeping genes: (A) Gapdh, (B) Hprt, (C) Ppia, (D) 18S rRNA, 
(E) β2m, (F) Oaz1, (G) Gusb, (H) Ywhaz, (I) Sdha and (J) Rpl13a. Fold change in gene expression analysed by the 2-
ΔC'T (see methods for details). Data are mean ± S.E.M., n = 3: * p < 0.05, ** p < 0.01, # p < 0.0001 vs. control.
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decreasing significantly at 48 h (p < 0.05) and 72 h (p <
0.01) (Figure 2F). Changes in Gapdh mRNA levels were
found to be significant between time groups (p < 0.0001).
Gapdh expression decreased at 30 min (p < 0.01), 2 h (p
< 0.05) and 6 h (p < 0.01) in comparison with the control
group (Figure 2G). mRNA expression was invariable
under in-vivo ischaemic brain conditions for the Sdha (p
= 0.067), Hprt (p = 0.236) and Ywhaz (p = 0.244) genes
(Figure 2H–2J).
The stability of these three genes was evaluated using
geNorm and NormFinder algorithms. GeNorm identi-
fied Ywhaz and Sdha as the most stable pairwise combi-
nation of reference genes for the in-vivo ischaemia
Effects of pMCAO in expression of housekeeping genes: (A) β2m, (B) Rpl13a, (C) Oaz1, (D) Ppia, (E) Gusb, (F) 18SrRNA, (G)  Gapdh, (H) Sdha, (I) Hprt and (J) Ywhaz Figure 2
Effects of pMCAO in expression of housekeeping genes: (A) β2m, (B) Rpl13a, (C) Oaz1, (D) Ppia, (E) Gusb, (F) 
18SrRNA, (G) Gapdh, (H) Sdha, (I) Hprt and (J) Ywhaz. Fold change in gene expression analysed by the 2-ΔC'T (see 
methods for details). Data are mean ± S.E.M., n = 6: * p < 0.05, ** p < 0.01, # p < 0.0001 vs. control.
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model (Figure 3A). Figure 3B shows the pairwise varia-
tion value (V) between two sequential normalization
factors containing an increasing number of genes. As we
only analysed three genes, the figure shows the pairwise
variation value of V2/3 (0.000). According to Vandesom-
pele et al. [12], the ideal pairwise variation value is less
than 0.15 and therefore two genes, in our case Ywhaz
and Sdha, are enough for normalization. NormFinder
identified Ywhaz as the most stable gene with a stability
value of 0.023 and, as with geNorm, the best two genes
for normalization were Ywhaz and Sdha with a stability
value of 0.022 (Table 1).
Gene expression stability and determination of the optimum number of genes for normalization of the candidate reference  genes for the in-vivo ischaemia model using geNorm analysis Figure 3
Gene expression stability and determination of the optimum number of genes for normalization of the candi-
date reference genes for the in-vivo ischaemia model using geNorm analysis. (A) Expression stability plot showing 
average expression stability values M. (B) Pairwise variation analysis to determine the optimal number of reference genes for 
use in RT qPCR data normalization. The use of the two most stable genes is sufficient for accurate normalization (cutoff 0.15 
according to [12])
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Discussion
The selection of the housekeeping gene is crucial to the
normalization of quantitative gene expression results.
This is even more important in those settings in which
gene expression is severely affected, as after cerebral
ischaemia.
No validated housekeeping genes have been reported for
the relative quantification of the mRNA expression profile
activated in in-vitro ischaemic conditions. Our present
study discards the use of Gapdh, Ppia, β2m, 18S rRNA,
Hprt, Oaz1, Gusb and Ywhaz as reference genes and finds
Rpl13a and Sdha to be the best control genes for the in-
vitro model in the conditions we have tested.
With regards to the pMCAO model, four studies have
reported the suitability of several reference genes for this
ischaemia model. In Table 2 we summarise the methodolo-
gies employed and results obtained both for previously pub-
lished and the present studies. Earlier investigations only
tested from two to four candidate control genes finding
invariable expressions for Rpl13a, Hprt, Ppia and Gapdh
genes. In the case of Gapdh, results were contradictory: three
studies validated the gene [16,21,22] whereas another
rejected it [23]. Our results show that Gapdh, Rpl13a and
Ppia together with other candidate genes, namely β2m,
Gusb, 18S rRNA and Oaz1, are not appropriate as house-
keeping genes for the pMCAO model. As previously reported
by Meldgaard et al. when using the pMCAO model in mice
[16], we have found Hprt to be a suitable housekeeping gene
for the in-vivo ischaemia model. Moreover we have identi-
fied two new housekeeping genes for this model, Sdha and
Ywhaz, which have not been previously analysed. According
to the results obtained with the NormFinder and geNorm
algorithms, these two genes are more stable and so the best
suited for normalization of relative quantification gene
expression studies. Several factors have an influence on the
variability of control genes and may lead to differences
between studies. In the same way that gene control expres-
sion may vary depending on whether the model is perma-
nent (pMCAO) or transient (tMCAO) [27], different
methodologies employed to perform the pMCAO, electro-
cautery or intraluminal filament, may have an influence on
the gene expression. Sample collection and the control sam-
ple used are other factors which must be taken into consider-
ation. Three different cerebral regions have been collected in
each previous study: the whole of the infarcted cortex
[21,22], the whole of the infarcted hemisphere [16] and the
ischaemic penumbra cortex [23]. In our study we have col-
lected the infarcted and peri-infarcted cortical area to analyse
changes in gene expression in the affected region. With
regards to the control sample there are also different possibil-
ities: brain samples from sham or naive rats, or healthy con-
tralateral hemispheres. We consider sham rats to be the best
control because this control minimises bias due to surgery.
In our opinion, the use of the healthy contralateral hemi-
sphere may lead to erroneuos conclusions because studies
have reported structural changes as well as changes in gene
expression in the contralateral hemisphere after ischaemia
[28-30]. Finally, the time course studied is also a relevant fac-
tor. We have validated Sdha, Ywhaz and Hprt as a suitable
housekeeping genes for the pMCAO model conducting an
analysis of the control situation and after ischaemia at fre-
quent time intervals up to 72 hours, which vary from those
used in earlier studies [16,21-23]. Considering all the varia-
bles that may influence gene expression, the validation of
candidate reference genes in each individual experimental
condition is crucial.
The geNorm [12] and NormFinder [11] algorithms are
now widely used to determine the most stable reference
genes from a set of candidates genes with invariable
expression [26,31-34]. We have only used algorithms on
genes identified as stable housekeeping genes in the in-
vivo model in our analysis as the software requires a min-
imum of three genes for the analysis.
In order to check the value of the validation of endog-
enous controls, we have used different housekeeping
genes analysed in this study to normalise the expression of
cyclooxygenase 2 (Cox2) and Bcl2, genes which are
known to be involved in cerebral ischaemia (data not
shown). Cox2 is an inflammatory mediator gene which
undergoes a significant increase due to ischaemia [35,36].
Bcl2 is a protooncogene that codifies an antiapoptotic
protein, which has been described as participating in neu-
roprotective mechanisms in ischaemic stroke although
changes in the expression are limited to an increase in the
neurons within the peri-infarct region [37-39]. In the two
cases we have observed differences in the results obtained
Table 1: Stability values of housekeeping genes obtained by NormFinder
Ranking Gene name Stability value
1 Ywhaz 0.023
2S d h a 0 . 0 3 4
3H p r t 0 . 0 6 6
Best combination of two genes Sdha and Ywhaz 0.022BMC Molecular Biology 2009, 10:57 http://www.biomedcentral.com/1471-2199/10/57
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when suitable and unsuitable control genes are used.
These are even more critical when the differences in
expression of the analysed gene are minor, as is the case
with Bcl2, which has a different expression pattern
depending on the housekeeping gene that is used.
Conclusion
In designing any study into relative gene expression quan-
tification it is necessary to perform a validation of the
housekeeping genes used which takes into account the
specific experimental conditions to be encountered and
the time course to be employed.
We report a detailed investigation of the effects of experi-
mental ischaemia on the expression of potential house-
keeping genes including genes typically used and new
candidates as internal controls in qRT-PCR assays. This
analysis was facilitated by the sensitivity and efficiency of
real-time quantitative PCR. We determined that Gapdh,
Rpl13a and Ppia, which have previously been validated as
housekeeping genes in quantitative expression studies
with the pMCAO model, had significant differences in
their expression in our samples collected at different time
points. Our study confirms the suitability of Hprt as a
housekeeping gene for this in-vivo model and identifies
two new housekeeping genes, Sdha and Ywhaz, which are
more stable than Hprt. We have also identified, to the best
of our knowledge for the first time, reference genes
(Rpl13a and Sdha) for the OGD in-vitro model using pri-
mary astrocyte cultures.
The study also highlights the importance of validating
control genes for each individual study as gene expression
is influenced by many different factors which can lead to
mistaken conclusions.
Methods
All procedures were approved by the Committee of Ani-
mal Care of the Universidad Complutense de Madrid, in
accordance with the regulations of the European Union
(86/609/CEE) and Spanish legislation (RD223/88).
Reference gene selection
Candidate reference genes were selected from those most
commonly used in the literature [14,24-26], a new candi-
date [10], and those previously described as suitable for
pMCAO studies [16,21-23] (see Table 3).
In-vitro ischaemia
Rat astrocyte cultures
Primary astrocyte cultures were prepared from neonatal
(P0) Wistar rat cortex, as previously described [40,41].
Table 2: Housekeeping gene validation in the pMCAO model
Harrison DC 2000 Medhurst AD 2000 Meldgaard M 2006 Tian YF 2007 Gubern C
Focal ischaemia 
model
pMCAO intraluminal 
filament
pMCAO intraluminal 
filament
pMCAO 
electrocautery
pMCAO intraluminal 
filament
pMCAO 
electrocautery
Animal Male Sprague-Dawley 
rats
Male Sprague-Dawley 
rats
Male SJL mice Male Sprague-Dawley 
rats
Male Fisher rats
Collected sample Whole infarcted cortex Whole infarcted cortex Whole infarcted 
hemisphere
Ischaemic penumbra 
cortex
Infarcted and peri-
infarcted cortex region
Time points Naive, 3, 6, 12 and 24 h 
(pMCAO and sham)
Contralateral 
hemisphere, 6 and 24 h
Sham, 30 min, 1, 2, 4, 6, 
12, 24 and 48 h, 5 and 
10d
Sham, 2 h, 24 h, 3, 7 
and 21d
Sham, 30 min, 2, 6, 24, 
48 and 72 h
Real-Time PCR Custom TaqMan assays Custom TaqMan assays Custom TaqMan assays SyberGreen Inventoried TaqMan 
assays
Method Standard curve Standard curve %mRNA = 100 × 
(1+E)ΔCT
2-ΔC'T 2-ΔC'T
Statistical analyses ANOVA Student's unpaired t-
test
Kruskal-Wallis + 
Dunn's
ANOVA + Tukey ANOVA + Dunnett's
Suitable controls Ppia & Gapdh Ppia & Gapdh Hprt & Gapdh Rpl13a & Ppia Hprt, Sdha & Ywhaz
Unsuitable controls β-actin Gapdh, β-actin Oaz1, Gapdh, Ppia, 
Rpl13a, B2m, Gusb, 
18SrRNABMC Molecular Biology 2009, 10:57 http://www.biomedcentral.com/1471-2199/10/57
Page 8 of 10
(page number not for citation purposes)
Exposure of astrocyte culture to oxygen-glucose deprivation (OGD)
Oxygen-glucose deprivation was performed as previously
described [42]. Culture medium was replaced by a solution
containing (in mM) NaCl (130), KCl (5.4), CaCl2 (1.8),
NaHCO3 (26), MgCl2 (0.8), NaH2PO4 (1.18) and 2% FS
bubbled with 95% N2/5% CO2 for OGD cells (OGD solu-
tion). OGD cells were transferred to an anaerobic chamber
(Forma Scientific, Hucoa Erloss, Spain) containing a gas mix-
ture of 95% N2/5% CO2 and humidified at 37°C, and
maintained at a constant pressure of 0.15 bar. Time of expo-
sure to OGD was 180 min. OGD was terminated by replac-
ing the exposure medium with oxygenated MEM containing
0.6% glucose, 0.029% glutamine, 50 I.U./ml penicillin, 50
Ag/ml streptomycin, 10% FS (reperfusion medium) and
returned to the normoxic incubator. Control cultures in a
solution identical to OGD solution except that it contained
glucose (33 mM; control solution) were kept in the nor-
moxic incubator for the same time period as the OGD, and
then incubation solution was replaced with the reperfusion
buffer. Cultures were returned to the normoxic incubator
until the end of the experiment.
Experimental groups
Astrocyte samples were collected from controls and from
the OGD group at 0 minutes, 30 minutes, 2 hours, 6
hours, 24 hours and 48 hours after reperfusion (n = 5 in
each group). Astrocytes were collected in RNA Protect Cell
Reagent (Qiagen, Barcelona, Spain) and frozen at -80°C
until RNA isolation was undertaken.
In-vivo cerebral ischaemia
Permanent middle cerebral artery occlusion (pMCAO) in rats
Experiments were performed on male Fischer rats weigh-
ing 250–300 g. Rats were anaesthetised with 2.5% haloth-
ane in a mixture of 70% nitrogen/30% oxygen.
Permanent focal cerebral ischemia was induced by liga-
ture of the left common carotid artery (CCA) and occlu-
sion of the ipsilateral distal middle cerebral artery (MCA)
as previously described [41,42]. Briefly, for the CCA liga-
ture, a midline ventral cervical incision was made, and the
CCA was isolated and permanently occluded with a silk
ligature. For the MCA occlusion, a 1-cm incision perpen-
dicular to the line connecting the lateral canthus of the left
eye and the external auditory canal was made to expose
and retract the temporalis muscle. A 2-mm burr hole was
drilled and the MCA was exposed by cutting and retracting
the dura. The MCA was elevated and cauterised. Rats in
which the MCA was exposed but not occluded served as
sham-operated controls (SHAM). Following surgery, sub-
jects were returned to their cages and allowed free access
to water and food. The body temperature of animals was
monitored throughout the experiment and was main-
tained at 37.5 ± 0.5°C using a heating pad.
Experimental groups
Brain were removed and cortical infarcted and peri-inf-
arcted tissue was collected from controls and the pMCAO
group at 30 minutes, 2 hours, 6 hours, 24 hours, 48 hours
and 72 hours after artery occlusion (n = 6 in each group).
Samples were quickly transferred to 1.5 mL tubes and fro-
zen at -80°C until RNA isolation was undertaken.
RNA extraction, quantification and retrotranscription
Cerebral cortex frozen samples were immediately trans-
ferred to QIAzol lysis reagent (Qiagen) and then homog-
enised using an Ultra-Turrax T25 homogeniser. RNA was
isolated using the RNeasy® Lipid Tissue Mini Kit (Qiagen)
in accordance with the manufacturer's instructions and
treated with DNase (RNase-free DNase Set, Qiagen) in
order to remove any trace of genomic DNA. RNA was
quantified spectrophotometrically (GeneQuant, Bio-
chrom) at 260 nm (A260) and purity was estimated by an
A260/A280 ratio > 1.8. The integrity, purity, and amount of
RNA were verified by visualization of rRNAs after electro-
phoresis on agarose gel.
Total RNA was isolated from primary glial cultures using
the RNeasy® Plus Mini Kit (Qiagen) and total RNA concen-
Table 3: Candidate reference genes
Gene Symbol Gene Name TaqMan Assay Number* Genebank accession
Hprt Hypoxanthine phosphoribosyltransferase Rn01527840_m1 NM_012583
Gapdh Glyceraldehyde-3-phosphate dehydrogenase Rn99999916_s1 NM_017008
Oaz1 Ornithine decarboxylase antizyme 1 Rn00821793_g1 NM_139081
β2m Beta-2 microglobulin Rn00560865_m1 NM_012512
Ppia Peptidyl-prolyl cis-trans isomerasa Rn00690933_m1 NM_017101
Rpl13a Ribosomal Protein L13A Rn00821946_g1 NM_173340
18S Eukaryotic 18S rRNA Hs99999901_s1 X03205.1
Ywhaz Tyrosine 3-monooxygenase Rn00755072_m1 NM_013011.3
Sdha Succinate dehydrogenase complex, subunit A Rn00590475_m1 NM_130428.1
Gusb Glucuronidase, beta Rn00566655_m1 NM_017015.2
*"_m" indicates an assay whose probe spans an exon junction and will not detect genomic DNA. "_s" indicates an assay whose probes and primers 
are designed within a single exon and, hence, will detect genomic DNA. "_g" indicates an assay that may detect genomic DNA as the assay probe 
and primers may also be within a single exon.BMC Molecular Biology 2009, 10:57 http://www.biomedcentral.com/1471-2199/10/57
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tration was measured by fluorescence using a Quant-iT
RNA Assay Kit (Invitrogen, Barcelona, Spain). Manufac-
turers' instructions were followed in both cases.
2 μg of RNA from each cortex samples and 1 μg of RNA
from astrocyte samples were reverse transcribed using a
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Barcelona, Spain) according to the manufac-
turer's instructions. Two independent RT reactions were
performed for all samples.
Real-time PCR
RT-Q-PCR reactions were carried out for all genes of inter-
est in each sample using specific TaqMan® Gene Expres-
sion Assays (Table 3) and an ABI PRISM® 7000 Instrument
(Applied Biosystems). Each reaction was performed in a
final volume of 25 μL containing 11.25 μL cDNA diluted
with H2O, 1.25 μL TaqMan® Gene Expression Assay and
12.5 μL of TaqMan® Universal PCR Master Mix (Applied
Biosystems). Amplifications were performed starting with
a 2 min activation step for Amperase UNG at 50°C, 10
min template denaturation step at 95°C, followed by 40
cycles of 95°C for 15s and 60°C for 1 min. As we used
TaqMan® Gene Expression Assays validated with PCR effi-
ciency near 100% for all of them, the expression of each
housekeeping gene was obtained using the 2-ΔC'T method,
a modification of the 2-ΔΔCt method described by K. Livak
et al., where ΔCt (CtTime X - CtControl) and Control is the cal-
ibrator sample representing the 1× expression of each
gene [13,24]. All samples were run in triplicate and aver-
age values were calculated. Two independent reverse tran-
scriptions were tested for each gene.
As some of the Taqman Gene Expression assays employed
are not cDNA specific, we confirmed no genomic DNA
contamination of our samples using no-reverse transcrip-
tion controls. A no-reverse transcription control is a reac-
tion that has been prepared for reverse transcription with
RNA and all the components of the retrotranscription kit
except for reverse transcriptase.
Statistical analysis
Data are mean ± standard error of the mean (SEM). A sta-
tistical test was applied to look for significant differences
between experimental conditions for each candidate con-
trol gene in each experimental model. The variance equal-
ity hypothesis was confirmed for each gene in the two
experimental models as Bartlett's test failed to reveal any
significant variance with a confidence level of 95% (data
not shown). A one-way analysis of variance (ANOVA) test
was therefore conducted, followed by Dunnett's post-hoc
analysis to compare each time set against the control
group mean. A p value < 0.05 was considered statistically
significant. Calculations were performed using the 11.0.0
version of SPSS software (SPSS Inc).
Determination of reference gene expression stability
After determining which housekeeping genes had an
invariable expression in the in-vivo model using 2-ΔC'T
method and ANOVA + Dunnett's post hoc analysis, we
used two publicly available software tools, geNorm [12]
and NormFinder [11], to analyse their gene expression
stability. GeNorm calculates a gene-stability measure M,
which is the average pairwise variation of a particular gene
compared with all other candidate reference genes. A
lower value of M indicates the greater stability of the ref-
erence gene. NormFinder estimates the overall expression
variation of the candidate normalization genes and the
variation between sample subgroups of the sample set
using a model-based approach.
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